EDIT
Editas Medicine, Inc.
NASDAQ · Healthcare · Biotechnology · US
$3.17
+2.92%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 27.91x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 4.62x
- Price / sales
- 10.36x
- Price / cash flow
- -4.06x
Enterprise value
- Enterprise value
- $290.7M
- EV / sales
- 6.18x
- EV / EBITDA
- -4.14x
- EV / EBIT
- -3.54x
- Market cap
- $486.8M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026